FORTRESS BIOTECH, INC. received a stock award from AVENUE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2026ACC: 0001429260-26-000004
10% Owner
Since Dec 2022
+111.21K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
111.21K acquired
Non-Derivative Transactions1
COMMON STOCK, PAR VALUE $0.0001
Direct
Shares
+111.21K
Price / share
—
Trade value
—
% of position
33.9%
1/2/2026
328.52K→439.73K
Total
Net shares
+111.21K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK, PAR VALUE $0.0001 Direct | 1/2/2026 | A · Award | +111.21K | — | — | 33.9% | 328.52K | 439.73K |
| Total | +111.21K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported